Results 1 to 10 of about 2,212 (184)

Sustained Pericarditis Recurrence Risk Reduction With Long‐Term Rilonacept [PDF]

open access: yesJournal of the American Heart Association
Background Rilonacept, a once‐weekly interleukin‐1 alpha and beta cytokine trap, reduced pericarditis recurrence in the phase 3 study, RHAPSODY (Rilonacept Inhibition of Interleukin‐1 Alpha and Beta for Recurrent Pericarditis: A Pivotal Symptomatology ...
Basil S Lewis   +2 more
exaly   +7 more sources

A Comprehensive Clinical Evaluation of Rilonacept in the Treatment of Recurrent Pericarditis: A Systematic Review [PDF]

open access: yesJournal of Inflammation Research
Yue Yu, Jiajing Chen, Zhao Zhao, Moting Qian, Yufei Zhang, Chunlai Ma Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, 200040, People’s Republic of ChinaCorrespondence: Chunlai Ma, Email chunlaima@126.comObjective: Recurrent ...
Yu Y   +5 more
exaly   +6 more sources

Comprehensive Clinical Analysis of Rilonacept in the Treatment of Cryopyrin-Associated Periodic Syndromes: A Systematic Review [PDF]

open access: yesJournal of Multidisciplinary Healthcare
Tian Zhang,1 Yue Yu,2 Jiajing Chen,2 Zhao Zhao,2 Moting Qian,2 Yufei Zhang,2 Chunlai Ma,2 Feng Chang3 1Institute of Science and Technology, China Pharmaceutical University, Nanjing, 211198, People’s Republic of China; 2Department of Pharmacy, Huashan ...
Zhang T   +7 more
exaly   +6 more sources

Inhibition of Interleukin-1 With Rilonacept Is Not Effective in Cold Urticaria—Results of a Randomized, Placebo-Controlled Study [PDF]

open access: yesClinical and Translational Allergy, 2023
Background Cold urticaria (ColdU) is characterized by pruritic wheals following exposure of the skin to cold. Many patients show insufficient response to antihistamines, the first line treatment.
Karoline Krause   +2 more
exaly   +4 more sources

Interleukin‐1 Trap Rilonacept Improved Health‐Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY [PDF]

open access: yesJournal of the American Heart Association, 2022
Background Recurrent pericarditis is characterized by painful flares and inflammation, which negatively impact health‐related quality of life. RHAPSODY (rilonacept inhibition of interleukin‐1 alpha and beta for recurrent pericarditis: a pivotal ...
Michelle Z Lim-Watson   +2 more
exaly   +4 more sources

Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy [PDF]

open access: yesDrug Design, Development and Therapy
Panayotis K Vlachakis, Panagiotis Theofilis, Stergios Soulaidopoulos, Emilia Lazarou, Konstantinos Tsioufis, George Lazaros First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens ...
Panagiotis Theofilis   +2 more
exaly   +5 more sources

IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives

open access: yesFrontiers in Immunology, 2021
Autoinflammatory diseases (AIDs) represent a rare and heterogeneous group of disorders characterized by recurrent episodes of inflammation and a broad range of clinical manifestations.
Hana Malcova   +8 more
doaj   +1 more source

Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis

open access: yesReviews in Cardiovascular Medicine, 2023
Acute pericarditis is the most frequent pericardial disease characterized by inflammation of the pericardial layers resulting in pain, dyspnea and fatigue.
Aldo Bonaventura   +8 more
doaj   +1 more source

Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders

open access: yesFrontiers in Immunology, 2022
BackgroundThe cytokine interleukin (IL)-1 plays a pivotal role in immune-mediated disorders, particularly in autoinflammatory diseases. Targeting this cytokine proved to be efficacious in treating numerous IL-1-mediated pathologies. Currently, three IL-1
Dennis D. Arnold   +3 more
doaj   +1 more source

Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept

open access: yesBMC Cardiovascular Disorders, 2021
Background Impact of recurrent pericarditis (RP) on patient health-related quality of life (HRQoL) was evaluated through qualitative patient interviews and as an exploratory endpoint in a Phase 2 trial evaluating the efficacy and safety of rilonacept (IL-
David Lin   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy